Global Microneedle Drug Delivery Systems Market Forecast (2024–2032)
The Microneedle Drug Delivery Systems Market was valued at USD 6.1 billion in 2023 and is projected to reach USD 11.6 billion by 2032, growing at a CAGR of 7.4% during the forecast period from 2024 to 2032. The market is witnessing robust growth driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders, which collectively account for over 70% of global deaths according to the World Health Organization (WHO).